European Biotech Acquisition (EBACU) Stock Price, News & Analysis

Company Overview

European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Key Stats

• Today's Range: $10.31 to $11.97
• 50-Day Range: $9.75 to $10.01
• 52-Week Range: $9.75 to $10.49
• Volume: 5,714 shs
• Average Volume: 2,500 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EBACU Stock Analysis - Frequently Asked Questions

When did European Biotech Acquisition IPO?

European Biotech Acquisition (EBACU) raised $100 million in an initial public offering (IPO) on Tuesday, March 16th 2021. The company issued 10,000,000 shares at a price of $10.00 per share. Credit Suisse and Kempen & Co. served as the underwriters for the IPO.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:EBACU
• CIK: 1841258
• Web: www.lspvc.com
• Phone: 31 20 664 55 00
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A